Skip to main content

Table 9 Oocyte Quality

From: Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study

  

Previous Treatment in Main Study

 

Total Group

Ovaleap®

Gonal-f®

Cycle 2

N = 146

N = 80

N = 66

Oocyte quality, n (%) oocytes

   

 Z1 (Best)

162 (18.4)

87 (17.6)

75 (19.3)

 Z2

363 (41.2)

210 (42.6)

153 (39.4)

 Z3

234 (26.6)

129 (26.2)

105 (27.1)

 Z4 (Worst)

122 (13.8)

67 (13.6)

55 (14.2)

Total 2 PN oocytes

881 (100.0)

493 (100.0)

388 (100.0)

Cycle 3

N = 60

N = 33

N = 27

Oocyte quality, n (%) oocytes

   

 Z1 (Best)

71 (17.4)

34 (15.7)

37 (19.5)

 Z2

160 (39.3)

84 (38.7)

76 (40.0)

 Z3

127 (31.2)

68 (31.3)

59 (31.1)

 Z4 (Worst)

49 (12.0)

31 (14.3)

18 (9.5)

Total 2 PN oocytes

407 (100.0)

217 (100.0)

190 (100.0)

  1. PN pronucleus; Z score zygote scoring system of Scott et al. [10]